naltrexone has been researched along with enkephalin, met(2)-pronh2(5)- in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bajusz, S; Berzétei, IP; Rónai, AZ; Székely, JI | 1 |
Nishiyama, N; Schwartz, JP; Taniwaki, T; Wilson, D | 1 |
Carr, JA; Saland, LC; Samora, A; Tejeda, D | 1 |
3 other study(ies) available for naltrexone and enkephalin, met(2)-pronh2(5)-
Article | Year |
---|---|
The in vitro pharmacology of D-Met2,Pro5-enkephalinamide.
Topics: Animals; Endorphins; Enkephalin, Methionine; Enkephalins; In Vitro Techniques; Kinetics; Male; Muscle Contraction; Muscle, Smooth; Naltrexone; Narcotics; Nictitating Membrane; Rats; Receptors, Opioid; Vas Deferens | 1981 |
Receptor-mediated regulation of neuropeptide gene expression in astrocytes.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Astrocytes; Benzomorphans; Brain; Enkephalin, Methionine; Etorphine; Gene Expression Regulation; Morphine; Naltrexone; Nerve Tissue Proteins; Neuropeptides; Organ Specificity; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Opioid | 1994 |
Effects of the enkephalin analog (D-Met2,Pro5)-enkephalinamide on alpha-melanocyte-stimulating hormone secretion.
Topics: alpha-MSH; Animals; Dose-Response Relationship, Drug; Enkephalin, Methionine; Male; Naltrexone; Pituitary Gland; Rats; Rats, Sprague-Dawley; Time Factors | 1993 |